CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs - Centers for Medicare & Medicaid Services | CMS (.gov)
CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B DrugsNegotiations Will Occur in 2026 With Negotiated Prices Effective in 2028